Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration.
2005
Mechanisms of Thrombus Formation
2008 Standout
Auditory and non-auditory effects of noise on health
2013 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Platelet adhesion in atrial fibrillation
2007
Intracerebral haemorrhage
2009 Standout
D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation
2002
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Elevated Platelet Microparticle Levels in Nonvalvular Atrial Fibrillation
2007
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
2004
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Trends in case-fatality in 22 968 patients admitted for the first time with atrial fibrillation in Scotland, 1986–1995
2002
Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
2003
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis
2005
Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation
2000
Antithrombotic Therapy for VTE Disease
2016 Standout
Anticoagulant Therapy Modifies Fibrinolytic Dysfunction in Chronic Atrial Fibrillation
2000
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
ABC of heart failure: History and epidemiology
2000
Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation
2007
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation
2004
Prognostic value of blood pressure in acute stroke
2002
Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia
2003
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
2010
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation
2004
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
2004 StandoutNobel
Left Atrial Appendage Function and Abnormal Hypercoagulability in Patients With Atrial Flutter
2003
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
2013
Applying research evidence to individuals in primary care: a study using non-rheumatic atrial fibrillation
1999
Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke
2009
Plasma adenosine levels and platelet activation in patients with atrial fibrillation
1999
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Users' Guides to the Medical Literature
2000 Standout
Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion
2000
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism
2008
Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis
2003
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: Secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial
2006
Platelets and the immune continuum
2011 Standout
Nonchannel drug targets in atrial fibrillation
2004
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
2006
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996
2001
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
2007 Standout
Cognitive and Behavioral Outcomes of School-Aged Children Who Were Born Preterm
2002 Standout
Effects of Aspirin and Clopidogrel versus Oral Anticoagulation on Platelet Function and on Coagulation in Patients with Nonvalvular Atrial Fibrillation (CLAFIB)
2002
Mejoría de la función fibrinolítica tras el tratamiento anticoagulante en la fibrilación auricular reumática crónica
1999
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy
2002
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation
2002
Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage
2001
Why Do Patients With Atrial Fibrillation Not Receive Warfarin?
2000
Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice
2003
Prothrombotic Activity Is Increased in Patients With Nonvalvular Atrial Fibrillation and Risk Factors for Embolism
2004
Atrial fibrillation and stroke prevention
2007
Platelet Activation in Embolic and Preembolic Status of Patients With Nonrheumatic Atrial Fibrillation
1997
Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients
2006
D-dimer level influences thromboembolic events in patients with atrial fibrillation
2005
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Dabigatran With or Without Concomitant Aspirin Compared With Warfarin Alone in Patients With Nonvalvular Atrial Fibrillation (PETRO Study)
2007
Antithrombotic Therapy in Atrial Fibrillation
2008
Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women
2003
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.
2007
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2004 Standout
Prolonged Activation of Hemostatic Markers Following Conversion of Atrial Flutter to Sinus Rhythm
2004
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation
1998
Early neurologic deterioration in intracerebral hemorrhage
2004
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Relationship of interleukin-6 and C-Reactive protein to the prothrombotic state in chronic atrial fibrillation
2004
Soluble P-Selectin and the Risk of Future Cardiovascular Events
2001
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Platelet P-Selectin Levels in Relation to Plasma Soluble P-Selectin and β-Thromboglobulin Levels in Atrial Fibrillation
2002
Thrombotic Variables and Risk of Idiopathic Venous Thromboembolism in Women Aged 45-64 Years
2000
Effects of Fixed Low-Dose Warfarin, Aspirin-Warfarin Combination Therapy, and Dose-Adjusted Warfarin on Thrombogenesis in Chronic Atrial Fibrillation
2000
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
2007 Standout
Inflammation and Atherosclerosis
2002 Standout
A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project.
1997
Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation
2002
Identification, diagnosis and assessment of atrial fibrillation
2006
Hypertension and Exposure to Noise Near Airports: the HYENA Study
2007
Effects of Anticoagulation Intensity on Hemostatic Markers in Patients With Non-Valvular Atrial Fibrillation
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Effect of Blood Pressure During the Acute Period of Ischemic Stroke on Stroke Outcome
2003
Left Atrial Appendage Dysfunction in Chronic Nonvalvular Atrial Fibrillation is Significantly Associated With an Elevated Level of Brain Natriuretic Peptide and a Prothrombotic State.
2001
Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation
1999
Cerebrovascular Disease in African Americans
1998
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Increased Expression of P-Selectin on Platelets Is a Risk Factor for Silent Cerebral Infarction in Patients With Atrial Fibrillation
1998
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?
2003
Relationship between Flow Dynamics in the Left Atrium and Hemostatic Abnormalities in Patients with Nonvalvular Atrial Fibrillation.
1998
Fibrin D-Dimer and Coronary Heart Disease
2001
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of John Zarifis being referenced
ACUTE ADMISSIONS WITH HEART FAILURE TO A DISTRICT GENERAL HOSPITAL SERVING A MULTIRACIAL POPULATION
1997
Ambulatory Blood Pressure Monitoring in Atrial Fibrillation
1996
Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project
2002
An 8‐year follow‐up study of acute admissions with heart failure in a multiethnic population
2004
ACUTE ADMISSIONS WITH ATRIAL FIBRILLATION IN A BRITISH MULTIRACIAL HOSPITAL POPULATION
1997
Physician variation in the management of patients with atrial fibrillation.
1996
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension
1995
Ambulatory Blood Pressure Monitoring in Acute Stroke
1997
Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial Fibrillation
1996